OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation

Yan Cui, Ying Ying, Andrew van Hasselt et al. · 2008

Read OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation by Yan Cui, Ying Ying, Andrew van Hasselt et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002990.txt.

Description

Yan Cui, Ying Ying, Andrew van Hasselt and co-authors studied the tumor suppressor OPCML in 2008. Finding suppressor genes silenced by methylation helps reveal how tumors form and can yield biomarkers. Loss of DNA at chromosome region 11q25 is common in many tumors, including nasopharyngeal carcinoma.

OPCML sits in that region. The team reports it as a broad tumor suppressor across multiple carcinomas and lymphomas, frequently switched off by epigenetic means rather than mutation. Published in PLOS ONE, broad action across cancer types makes the gene notable for both biology and testing. The full text gives methods, results, and references for readers who want to check each step.

Catalog record

CREATORYan Cui, Ying Ying, Andrew van Hasselt et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002990

Browse the full library · About the Tower of Babel